INVUS GLOBAL MANAGEMENT, LLC purchased 1.54M shares of LEXICON PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $2.00M. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 2/4/2026ACC: 0001193125-26-037644
Director10% Owner
Since Feb 2026
+24.31M
Net shares
Net buyer
$54.98M
Total acquired
1
Open market trades
1B · 0S
4
Total transactions
24.31M acquired
Non-Derivative Transactions4
Common Stock
Indirect
Shares
+18.55M
Price / share
$1.30
Trade value
$24.12M
% of position
13.6%
2/2/2026
136.18M→154.73M
Common Stock
Indirect
Shares
+3.85M
Price / share
$1.30
Trade value
$5M
% of position
109.4%
2/2/2026
3.52M→7.36M
Common Stock
Indirect
Shares
+1.54M
Price / share
$1.30
Trade value
$2M
% of position
New position
2/2/2026
0.00→1.54M
Series B Convertible Preferred Stock
Indirect
Shares
+367.15K
Price / share
$65.00
Trade value
$23.86M
% of position
New position
2/2/2026
0.00→367.15K
Total
Net shares
+24.31M
Net value
$54.98M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 2/2/2026 | A · Award | +18.55M | $1.30 | $24.12M | 13.6% | 136.18M | 154.73M |
| Common Stock Indirect | 2/2/2026 | A · Award | +3.85M | $1.30 | $5M | 109.4% | 3.52M | 7.36M |
| Common Stock Indirect | 2/2/2026 | P · Purchase | +1.54M | $1.30 | $2M | New position | 0.00 | 1.54M |
| Series B Convertible Preferred Stock Indirect | 2/2/2026 | A · Award | +367.15K | $65.00 | $23.86M | New position | 0.00 | 367.15K |
| Total | +24.31M | $54.98M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned5.45M
Common Stock
IndirectShares owned35.40M
Common Stock
IndirectShares owned1.39M
Total
42.24M indirect42.24M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 5.45M | Indirect |
| Common Stock | 35.40M | Indirect |
| Common Stock | 1.39M | Indirect |
| Total | 42.24M | 42.24M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported